WSFS
GSK icon

Wilmington Savings Fund Society’s GSK GSK Stock Holding History

Wilmington Savings Fund Society’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$720K Sell
13,731
-264
-2% -$14K 0.02% 360
2026
Q1 		$772K Buy
13,995
+82
+0.6% +$4.44K 0.02% 345
2025
Q4 		$682K Sell
13,913
-1,131
-8% -$52.8K 0.02% 371
2025
Q3 		$649K Sell
15,044
-2,771
-16% -$108K 0.02% 365
2025
Q2 		$684K Sell
17,815
-1,248
-7% -$47.7K 0.01% 511
2025
Q1 		$739K Sell
19,063
-151
-0.8% -$5.53K 0.01% 478
2024
Q4 		$650K Sell
19,214
-34
-0.2% -$1.22K 0.01% 518
2024
Q3 		$787K Buy
+19,248
New +$787K 0.01% 466
2022
Q3 		– Sell
-11,287
Closed -$614K – 359
2022
Q2 		$614K Sell
11,287
-1,428
-11% -$78.8K 0.03% 238
2022
Q1 		$693K Hold
12,715
– – 0.03% 248
2021
Q4 		$701K Sell
12,715
-194
-2% -$10.1K 0.03% 261
2021
Q3 		$616K Sell
12,909
-444
-3% -$22.3K 0.02% 266
2021
Q2 		$665K Buy
13,353
+220
+2% +$10.6K 0.03% 263
2021
Q1 		$585K Sell
13,133
-752
-5% -$34.1K 0.02% 265
2020
Q4 		$639K Sell
13,885
-361
-3% -$16.6K 0.03% 253
2020
Q3 		$670K Sell
14,246
-1,218
-8% -$61K 0.03% 242
2020
Q2 		$788K Sell
15,464
-21
-0.1% -$1.08K 0.04% 233
2020
Q1 		$733K Buy
15,485
+72
+0.5% +$3.84K 0.04% 219
2019
Q4 		$905K Sell
15,413
-200
-1% -$11.1K 0.05% 194
2019
Q3 		$833K Sell
15,613
-146
-0.9% -$7.51K 0.05% 193
2019
Q2 		$788K Sell
15,759
-441
-3% -$22.1K 0.04% 203
2019
Q1 		$846K Sell
16,200
-124
-0.8% -$6.2K 0.05% 196
2018
Q4 		$779K Buy
16,324
+578
+4% +$28.5K 0.05% 195
2018
Q3 		$791K Sell
15,746
-187
-1% -$9.5K 0.04% 213
2018
Q2 		$802K Buy
15,933
+263
+2% +$13.2K 0.04% 212
2018
Q1 		$766K Buy
15,670
+1,160
+8% +$54K 0.04% 216
2017
Q4 		$643K Sell
14,510
-2,083
-13% -$96.2K 0.04% 232
2017
Q3 		$842K Buy
16,593
+44
+0.3% +$2.23K 0.05% 214
2017
Q2 		$892K Sell
16,549
-230
-1% -$12.3K 0.05% 210
2017
Q1 		$884K Sell
16,779
-80
-0.5% -$4.06K 0.05% 207
2016
Q4 		$811K Hold
16,859
– – 0.05% 211
2016
Q3 		$909K Sell
16,859
-3,611
-18% -$198K 0.06% 205
2016
Q2 		$1.11M Sell
20,470
-29
-0.1% -$1.53K 0.07% 201
2016
Q1 		$1.04M Sell
20,499
-2,160
-10% -$108K 0.07% 208
2015
Q4 		$1.14M Sell
22,659
-565
-2% -$28.8K 0.07% 203
2015
Q3 		$1.12M Sell
23,224
-512
-2% -$26.7K 0.07% 200
2015
Q2 		$1.24M Sell
23,736
-4,398
-16% -$248K 0.07% 200
2015
Q1 		$1.62M Sell
28,134
-1,762
-6% -$101K 0.09% 185
2014
Q4 		$1.6M Buy
29,896
+488
+2% +$27.3K 0.09% 189
2014
Q3 		$1.69M Sell
29,408
-1,566
-5% -$96K 0.1% 193
2014
Q2 		$2.07M Sell
30,974
-2,210
-7% -$150K 0.11% 183
2014
Q1 		$2.22M Buy
33,184
+1,017
+3% +$68.8K 0.12% 176
2013
Q4 		$2.15M Sell
32,167
-3,849
-11% -$250K 0.12% 181
2013
Q3 		$2.26M Sell
36,016
-4,598
-11% -$296K 0.14% 173
2013
Q2 		$2.54M Buy
+40,614
New +$2.58M 0.16% 162

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Wilmington Savings Fund Society's GSK Position: Q2 2026 in Review

Wilmington Savings Fund Society reduced its GSK (GSK) stake by 1.9% in Q2 2026, selling an estimated $14K and leaving 13,731 shares worth $720K. The position accounts for 0.02% of the portfolio, ranked #360.

Wilmington Savings Fund Society first reported a position in GSK in Q2 2013 and has held it in 45 quarters since. The position peaked at $2.54M in Q2 2013. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Wilmington Savings Fund Society held 13,731 shares of GSK worth $720K as of Q2 2026.
  • Wilmington Savings Fund Society sold 264 GSK shares in Q2 2026, an estimated $14K.
  • GSK made up 0.02% of Wilmington Savings Fund Society's portfolio in Q2 2026, its #360 holding.
  • Wilmington Savings Fund Society first reported a position in GSK in Q2 2013 and has held it in 45 quarters since.
  • Wilmington Savings Fund Society's GSK position peaked at $2.54M in Q2 2013.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Wilmington Savings Fund Society's 13F filing for Q2 2026, filed 28 Jul 2026.